Lixisenatide in patients with type 2 diabetes and acute coronary syndrome

M Pfeffer, B Clagett, R Diaz, et al, for the ELIXA Investigators

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2247-57
Journal	New England Journal of Medicine
Volume	373
DOIs	https://doi.org/10.1056/NEJMoa1509225
Publication status	Published - 2015

Keywords / Materials (for Non-textual outputs)

@article{93a14ea3b92e41b6b475089585d811ab,

title = "Lixisenatide in patients with type 2 diabetes and acute coronary syndrome",

keywords = "Type 2 diabetes, Cardiovascular outcomes",

author = "M Pfeffer and B Clagett and R Diaz and {et al} and {for the ELIXA Investigators} and Alan Jaap",

year = "2015",

doi = "10.1056/NEJMoa1509225",

language = "English",

volume = "373",

pages = "2247--57",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "MASSACHUSETTS MEDICAL SOC",

}

TY - JOUR

T1 - Lixisenatide in patients with type 2 diabetes and acute coronary syndrome

AU - Pfeffer, M

AU - Clagett, B

AU - Diaz, R

AU - et al, null

AU - for the ELIXA Investigators

A2 - Jaap, Alan

PY - 2015

Y1 - 2015

KW - Type 2 diabetes

KW - Cardiovascular outcomes

U2 - 10.1056/NEJMoa1509225

DO - 10.1056/NEJMoa1509225

M3 - Article

SN - 0028-4793

VL - 373

SP - 2247

EP - 2257

JO - New England Journal of Medicine

JF - New England Journal of Medicine

ER -